Deferred Tax Assets, Valuation Allowance of AVADEL PHARMACEUTICALS PLC from 31 Dec 2011 to 31 Dec 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
AVADEL PHARMACEUTICALS PLC quarterly Deferred Tax Assets, Valuation Allowance in USD history and change rate from 31 Dec 2011 to 31 Dec 2024.
  • AVADEL PHARMACEUTICALS PLC Deferred Tax Assets, Valuation Allowance for the quarter ending 31 Dec 2024 was $101,565,000, a 5.3% increase year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

AVADEL PHARMACEUTICALS PLC Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2024 $101,565,000 +$5,137,000 +5.3% 31 Dec 2024 10-K 03 Mar 2025 2024 FY
Q4 2023 $96,428,000 +$25,087,000 +35% 31 Dec 2023 10-K 03 Mar 2025 2024 FY
Q4 2022 $71,341,000 +$47,316,000 +197% 31 Dec 2022 10-K 29 Feb 2024 2023 FY
Q4 2021 $24,025,000 +$2,401,000 +11% 31 Dec 2021 10-K 29 Mar 2023 2022 FY
Q4 2020 $21,624,000 +$4,586,000 +27% 31 Dec 2020 10-K 16 Mar 2022 2021 FY
Q4 2019 $17,038,000 -$4,161,000 -20% 31 Dec 2019 10-K 09 Mar 2021 2020 FY
Q4 2018 $21,199,000 +$5,845,000 +38% 31 Dec 2018 10-K 16 Mar 2020 2019 FY
Q4 2017 $15,354,000 +$7,755,000 +102% 31 Dec 2017 10-K 15 Mar 2019 2018 FY
Q4 2016 $7,599,000 -$37,917,000 -83% 31 Dec 2016 10-K 16 Mar 2018 2017 FY
Q4 2015 $45,516,000 -$12,464,000 -21% 31 Dec 2015 10-K 28 Mar 2017 2016 FY
Q4 2014 $57,980,000 -$11,960,000 -17% 31 Dec 2014 10-K 15 Mar 2016 2015 FY
Q4 2013 $69,940,000 +$5,584,000 +8.7% 31 Dec 2013 20-F 01 Oct 2015 2014 FY
Q4 2012 $64,356,000 +$7,251,000 +13% 31 Dec 2012 20-F 01 Oct 2015 2014 FY
Q4 2011 $57,105,000 31 Dec 2011 20-F/A 30 Apr 2014 2013 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.